Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
‘but no way will this be the case for ABDX’
See above for STLs wrong prediction
I don't make predictions - never have; never will.
You don't really need one with this company JB.
I don't know about ODX, but no way will this be the case for ABDX.
Market cap now £8.9m with £7.6m of cash and it's still a lousy investment.
Absolutely shameless management. We have been taken for mugs time and time again.
They may come good but December but there’s too much on my shopping list to be interested in this space anymore. I’m going to add to my Petrobras and JRS positions. PBR if you like dividends is unreal at these levels
Hemo will come good by December (I'll remind you)
Hemo looks just as crap @pumpky. I should’ve dumped when you did your trading account. Will be a very long time until ABDX sees 14p again
Shameless
Have a look @(Hemo):Good luck with your next investment
F*** it. I’m out. Took a heavy loss but feel like these will be lucky to have the light on this time next year
How crap an update was that? 5p incoming!
If they do not have good revenue next year:they will be seriously short of money by then
Let’s face it, it’s a terrible update. The EU customer won’t (in my view) materialise and both of the other covid opps are stuck with regulators. Taiwan has added nothing to its EUA list since May, and Vatic are losing staff and been deathly silent. In that last respect, I did note page 4 of the last FDA virtual town hall;
Q: I was curious if the FDA has any recommendations or advice for saliva-based antigen home tests?
A: So we've seen quite a bit of attempts at saliva-based antigen tests. I don't know exactly why it's been such a challenge. You know, there are a lot of advantages if it would work, but it may be that there's a concentration that's needed, such as with a molecular test.
So some of the molecular tests have not worked quite well in saliva, but that may be due to the concentration effect in extraction. So if you want to attempt it, you would just follow the recommendations, if you want, for antigen test validation. The comparator for saliva would be a nasopharyngeal swab using a high sensitivity molecular central lab test.
I would double check with the FDA before using a comparator test to make sure that it's high sensitivity enough. And then thirty positives and thirty negatives if you're going for symptomatic individuals.
We have recommended to others that want to pursue saliva. If this is a new test, we would recommend that you also consider as a backup and anterior nares swab. So that if you should have any issues with saliva, at least you have anterior nares.
https://www.fda.gov/media/160670/download
Putting it mildly, this company has failed at every step since IPO complete ****show yet again.
I’m the mug holding since 60p was waiting for the right time to average down but there is nothing in this to make me think it won’t be throwing good money after bad.
Abingdon set for a good week? Not with those results:Should have sold the lot last week;only bonus is I can buy them back cheaper this week
7.6 million pounds, reduced overheads and Vatic still in play. Could have been worse.
Well it was a crap trading update.
Good luck to all those who have held on. Anyone joining now is surely looking at easy money.
Abingdoom set for a good week. Trading update incoming.
Yawnbingdon Health is a good one hahaha. I'm giving this share until year end then I'm out if we get no upward momentum. Too many bargains around tempting me :)
Ipo@96 pence:placing @25 pence"SP 9 pence:says it all really
Yawnbingdonhealth.
Coming on a year I've been invested now and barely a pulse. Come on Abingdon, give us some news